EADV Symposium at a glance
EADV Symposium 2026 in Athens highlights emerging developments in dermatology, from acne, hidradenitis suppurativa and atopic dermatitis to psoriasis, regenerative approaches and skin cancer.
Key themes include evolving treatment strategies, biologics, JAK inhibitors, biomarker-guided care and artificial intelligence applications in dermatology diagnosis, risk assessment and clinical workflows.
📅 Build your schedule around the topics that matter most.
📥 Download the EADVSymposium 2026_Preview_by_LucidQuest
EADV Symposium 2026: Key Developments in Dermatology Treatment
Acne, Hidradenitis Suppurativa, Rosacea and Follicular Disorders
Systemic inflammation, microbiome disruption, povorcitinib, IL-1β, GLP-1, anti-TNF monitoring, and rosacea genetics may refine sequencing.
Atopic Dermatitis Treatment and Immuno-Inflammatory Skin Diseases
GLOBOSTAD, ADhope1, TRuE-AD4, COAST, and SHORE may expand biologics, JAKs, barrier repair, and biomarker-guided care.
Psoriasis and Psoriatic Arthritis Treatment Advances
ICONIC, LATITUDE, CLEAR-1, DREAM, UnlIMMited, PRO-SPIRIT, and APEX may sharpen oral immunology and biologic differentiation.
Hair Loss, Pigmentary Disorders and Regenerative Dermatology
ALLEGRO, UP-AA, ROSE-G, MELATIDE, exosomes, PRP, lasers, and microneedling may expand regenerative and precision approaches.
Skin Cancer Treatment, Diagnosis and Specialty Dermatology
PD-1/PD-L1, LC-OCT, PUVA, sirolimus, syphilis screening, wart therapy, and phototherapy may refine specialty pathways.
Artificial Intelligence and Machine Learning at EADV Symposium 2026
AI for Patient Self-Diagnosis in Dermatology
AI tools are set to influence acne care, lesion delays, and dermato-allergology behavior, raising trust and accuracy concerns.
AI-Based Recognition of Inflammatory Skin Diseases
AI applications in HS, chronic urticaria, allergic dermatoses, and AD are expected to support earlier diagnosis and education.
Machine Learning for Skin Disease Risk Prediction
Canadian ML studies are expected to assess environmental and socioeconomic predictors in AD and systemic lupus erythematosus risk.
AI in Skin Cancer Detection and Referral
A CE Class III AI device is positioned to improve urgent suspected skin cancer referral conversion in diagnostic hubs.
AI for Melanoma and Histology Quantification
AI versus human CD8 assessment in CDKN2A-mutated melanoma is expected to test immune-cell precision.
AI Bias, Equity and Vitiligo Assessment
Multimodal skin-of-color evaluation and sim-to-real vitiligo models are expected to expose diagnostic gaps and improve assessment.
AI in Dermatology Workflows and Clinical Education
AI imagery, chatbots, LLM STI counseling, scribes, and frontier model benchmarking may test accuracy, workload, and reasoning.
Download LucidQuest’s EADV Symposium 2026 Preview Report
Download our EADV Symposium 2026 preview report for deeper analysis of emerging dermatology therapies, treatment differentiation, clinical developments and AI applications in skin health.
📅 Build your schedule around the sessions that matter most.
📥 Download the EADVSymposium 2026_Preview_by_LucidQuest
Contact us for end-to-end conference coverage.
